Financials

  • Market Capitalization 3.34 B
  • Employee 798
  • Founded 1993
  • CEO Catherine Owen Adams
  • Website www.acadia.com
  • Headquarter Delaware, United States
  • FIGI BBG000BHG9K0
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
11.61
Rapporto prezzo/fatturato
4.24

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1560
IDYA
IDEAYA Biosciences, Inc. - Common Stock
36.06 USD-0.14%-5.68%-6.34%+10.68%3.48 B USD
1561
XENE
Xenon Pharmaceuticals Inc. - Common Shares
35.81 USD-1.73%-5.21%-39.67%-12.21%3.47 B USD
1586
VKTX
Viking Therapeutics, Inc. - Common Stock
28.34 USD-0.60%-3.87%-10.60%-13.76%3.31 B USD
1590
ARQT
Arcutis Biotherapeutics, Inc. - Common stock
26.22 USD-1.35%+3.88%+9.02%+27.96%3.30 B USD

ACADIA Pharmaceuticals Inc. - Common Stock

Acadia Pharmaceuticals Inc. è un'azienda biofarmaceutica con sede a Del Mar, in California.

Notizie